Article Versions Notes

Mangia A, Scaglione F, Toniutto P, Pirisi M, Coppola N, Di Perri G, Alvarez Nieto G, Calabrese S, Hernandez C, Perrone V, et al. Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study. International Journal of Environmental Research and Public Health. 2021; 18(13):7144. https://doi.org/10.3390/ijerph18137144

Mangia, Alessandra, Francesco Scaglione, Pierluigi Toniutto, Mario Pirisi, Nicola Coppola, Giovanni Di Perri, Gema Alvarez Nieto, Stefano Calabrese, Candido Hernandez, Valentina Perrone, and et al. 2021. "Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study" International Journal of Environmental Research and Public Health 18, no. 13: 7144. https://doi.org/10.3390/ijerph18137144

Mangia, A., Scaglione, F., Toniutto, P., Pirisi, M., Coppola, N., Di Perri, G., Alvarez Nieto, G., Calabrese, S., Hernandez, C., Perrone, V., Degli Esposti, L., & Fagiuoli, S., on the behalf of a LHUs Study Group. (2021). Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study. International Journal of Environmental Research and Public Health, 18(13), 7144. https://doi.org/10.3390/ijerph18137144